AZARGA
AZARGA
Approved
DIN Number
02331624
Drug Class
Human
Market Date
Aug 25, 2009
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02331624
AIG Number0252645001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01ED51 TIMOLOL, COMBINATIONS
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:40.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
BRINZOLAMIDEActive
Strength: 1 % / W/V
Monograph: BRINZOLAMIDE
TIMOLOL (TIMOLOL MALEATE)Active
Strength: 0.5 % / W/V
Monograph: TIMOLOL (TIMOLOL MALEATE)